News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

SynergEyes Expands Launch of New Hybrid Contact Lens Design for Keratoconus Patients

9/4/2009 10:18:23 AM

CARLSBAD, Calif., Sept. 4 /PRNewswire/ -- SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, recently introduced a new advanced lens design for keratoconus patients. ClearKone(TM) is a revolutionary contact lens that takes advantage of the best features of the hybrid platform, providing superior visual acuity, centration, stability, and all-day comfort. The patent-pending design is optimized to vault the predominant irregularities of the keratoconic cornea, thus effectively restoring vision to a vast majority of irregular cornea patients, without compromising comfort or eye health, even in the most challenging cases. ClearKone(TM) is now available in the United States, Canada and Puerto Rico.

"SynergEyes recognized the need to develop a hybrid contact lens design that could fit a much broader spectrum of keratoconus patients, including oval cones, highly advanced central cones, decentered cones and depending on the specifics of the case, globus keratoconus and pellucid marginal degeneration," says Kellie Kaseburg, Vice President of Global Marketing for SynergEyes. "The ClearKone(TM) lens does just that and will allow many more keratoconus patients to experience the benefits of hybrid technology."

"The ClearKone(TM) hybrid contact lens gives keratoconus patients wearing RGP lenses or a piggyback system a new way to have clearer, more stable vision and better comfort," says Dr. Morris Sheffer of Charlotte, North Carolina. "The design of ClearKone(TM) enables the lens to center very well on irregularly shaped corneas, to provide crisper vision than any other contact lens we have tried. Since the lens is designed to 'vault' over the peak of the cornea, the comfort is also greatly improved. Our patients love the improvement in comfort and vision they get with ClearKone(TM)!"

Incorporating patented HyperBond(TM) technology and HydrolEyes(TM) surface science, the SynergEyes(R) contact lenses with FDA market clearance include: SynergEyes(R) A for naturally occurring ametropia, targeting patients with astigmatism, current gas permeable lens wearers, and patients demanding optimized vision; the SynergEyes(R) Multifocal lens for presbyopia; SynergEyes(R) KC and ClearKone(TM) for keratoconus; and the SynergEyes(R) PS for post-surgery and post-trauma refractive errors.

This release was issued through eReleases(TM). For more information, visit

SynergEyes, Inc.

Read at

comments powered by Disqus